8-K Announcements
6Material company update
May 21, 2026·SEC
Material company update
May 12, 2026·SEC
Material company update
Mar 30, 2026·SEC
PepGen Inc.(PEPG)Earnings, Financials & Key Ratios
PEPG•NASDAQ
Price updated Jun 19, 2026
AboutPepGen Inc., a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases. The company's lead product candidate is PGN-EDO51, an EDO peptide in Phase I clinical trials to treat individuals with Duchenne muscular dystrophy (DMD). It is also developing PGN-EDODM1, an EDO peptide-conjugated PMO for the treatment of myotonic dystrophy type 1, as well as EDO therapeutic candidates, such as PGN-EDO53, PGN-EDO45, and PGN-EDO44 for the treatment of DMD. The company was founded in 2018 and is headquartered in Cambridge, Massachusetts.Show more
- Revenue$0
- EBITDA-$92M+4.2%
- Net Income-$90M+0.4%
- EPS (Diluted)-2.12+25.6%
- ROE-67.39%+15.0%
PEPG Key Insights
PepGen Inc. (PEPG) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Trading at only 0.5x book value
✗Weaknesses
- ✗Profits declining 116.4% over 5 years
- ✗Weak momentum: RS Rating 10 (bottom 10%)
- ✗Shares diluted 33.7% in last year
- ✗Trading more than 30% below 52-week high
- ✗Low asset turnover indicates capital-intensive operations
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when PEPG posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
PEPG Price & Volume
PepGen Inc. (PEPG) stock price & volume — 10-year historical chart
Loading chart...
PEPG Growth Metrics
PepGen Inc. (PEPG) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years-
3 Years-
TTM-
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM24.42%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM32.91%
Return on Capital
10 Years-47.49%
5 Years-54%
3 Years-63.65%
Last Year-63.37%
PEPG Recent Earnings
PepGen Inc. (PEPG) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 8/12 qtrs (67%)
Q2 2026Latest
May 12, 2026Metric
Actual
Est
EPS
$0.26+16.1%
$0.31
Rev
—
—
Q2 2026
Mar 4, 2026Metric
Actual
Est
EPS
$0.27+32.5%
$0.40
Rev
—
—
Q4 2025
Nov 12, 2025Metric
Actual
Est
EPS
$0.52+17.5%
$0.63
Rev
—
—
Q3 2025
Aug 7, 2025Metric
Actual
Est
EPS
$0.70+17.6%
$0.85
Rev
—
—
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 12, 2026 | $0.26vs $0.31+16.1% | — |
| Q2 2026 | Mar 4, 2026 | $0.27vs $0.40+32.5% | — |
| Q4 2025 | Nov 12, 2025 | $0.52vs $0.63+17.5% | — |
| Q3 2025 | Aug 7, 2025 | $0.70vs $0.85+17.6% | — |
Based on last 12 quarters of dataView full earnings history →
PEPG Peer Comparison
PepGen Inc. (PEPG) competitors in RNA and Genome Editing Developers — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 SRPT | 1.85B | 17.53 | -2.46 | 15.58% | 2.98% | 4.89% | 0.91 | |
 FOLD | 4.55B | 14.49 | -164.85 | 20.05% | -4.27% | -12.02% | 1.76 | |
 RARE | 2.7B | 27.44 | -4.71 | 20.13% | -91.03% | -6.08% | ||
 CRSP | 5.22B | 54.09 | -8.36 | -89.97% | -138.57% | -30.88% | 0.21 | |
 EDIT | 263.37M | 2.69 | -1.49 | 25.39% | -281.59% | -6.77% | 2.81 | |
 NTLA | 1.76B | 15.67 | -4.11 | 16.92% | -5.97% | -57.27% | 0.14 | |
 IONS | 12.25B | 74.12 | -31.14 | 33.87% | -30.87% | -58.57% | 5.35 | |
 ALNY | 37.1B | 278.09 | 119.35 | 65.19% | 13.46% | 98.29% | 1.62 |
Compare PEPG vs Peers
PepGen Inc. (PEPG) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
PEPG Income Statement
PepGen Inc. (PEPG) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Revenue Growth % | - | - | - | - | - | - | - | - |
Cost of Goods Sold | 106K | 0 | 0 | 0 | 1.18M | 1.5M | 1.4M | 1.72M |
COGS % of Revenue | - | - | - | - | - | - | - | - |
Gross Profit | -106K▲ 0% | 0▲ 100.0% | 0▲ 0% | 0▲ 0% | -1.18M▲ 0% | -1.5M▼ 27.1% | -1.4M▲ 7.2% | -1.72M▲ 0% |
Gross Margin % | - | - | - | - | - | - | - | - |
Gross Profit Growth % | - | 100% | - | - | - | -27.11% | 7.18% | - |
Operating Expenses | 1.25M | 1.88M | 27.11M | 68.3M | 83.58M | 96.23M | 92.22M | 79.52M |
OpEx % of Revenue | - | - | - | - | - | - | - | - |
Selling, General & Admin | 628K | 853K | 8.11M | 14.22M | 16.64M | 21.26M | 22.57M | 22.56M |
SG&A % of Revenue | - | - | - | - | - | - | - | - |
Research & Development | 620K | 1.12M | 23.8M | 54.08M | 68.13M | 76.48M | 71.04M | 58.35M |
R&D % of Revenue | - | - | - | - | - | - | - | - |
Other Operating Expenses | 0 | -100K | -4.8M | 0 | -1.18M | -1.5M | -1.4M | -1000K |
Operating Income | -1.35M▲ 0% | -1.88M▼ 38.6% | -27.11M▼ 1344.3% | -68.3M▼ 151.9% | -84.77M▼ 24.1% | -97.74M▼ 15.3% | -93.61M▲ 4.2% | -81.23M▲ 0% |
Operating Margin % | - | - | - | - | - | - | - | - |
Operating Income Growth % | - | -38.63% | -1344.27% | -151.95% | -24.11% | -15.3% | 4.22% | - |
EBITDA | -1.25M | -1.77M | -26.93M | -67.81M | -83.58M | -96.23M | -92.22M | -80.84M |
EBITDA Margin % | - | - | - | - | - | - | - | - |
EBITDA Growth % | - | -41.59% | -1424.11% | -151.78% | -23.26% | -15.14% | 4.18% | 22.16% |
D&A (Non-Cash Add-back) | 106K | 110K | 178K | 493K | 1.18M | 1.5M | 1.4M | 391K |
EBIT | -1.35M | -1.88M | -27.11M | -68.3M | -84.77M | -90.6M | -93.61M | -81.23M |
Net Interest Income | 6K | 8K | 0 | 2.79M | 6.4M | 7.14M | 4.02M | 4.14M |
Interest Income | 6K | 8K | 0 | 2.79M | 6.4M | 7.14M | 4.02M | 4.14M |
Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Income/Expense | 8K | -12K | -172K | 2.9M | 6.21M | 7.14M | 4.01M | 4.08M |
Pretax Income | -1.35M▲ 0% | -1.89M▼ 40.3% | -27.28M▼ 1344.2% | -65.4M▼ 139.7% | -78.55M▼ 20.1% | -90.6M▼ 15.3% | -89.61M▲ 1.1% | -77.15M▲ 0% |
Pretax Margin % | - | - | - | - | - | - | - | - |
Income Tax | 0 | 0 | 0 | 3.71M | 73K | -617K | 49K | 49K |
Effective Tax Rate % | 0% | 0% | 0% | -5.67% | -0.09% | 0.68% | -0.05% | -0.06% |
Net Income | -1.35M▲ 0% | -1.89M▼ 40.3% | -27.28M▼ 1344.2% | -69.1M▼ 153.3% | -78.63M▼ 13.8% | -89.98M▼ 14.4% | -89.66M▲ 0.4% | -77.22M▲ 0% |
Net Margin % | - | - | - | - | - | - | - | - |
Net Income Growth % | - | -40.34% | -1344.2% | -153.3% | -13.78% | -14.44% | 0.36% | 24.42% |
Net Income (Continuing) | -1.35M | -1.89M | -27.28M | -69.1M | -78.63M | -89.98M | -89.66M | -77.2M |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EPS (Diluted) | -0.06▲ 0% | -0.18▼ 199.5% | -1.22▼ 577.8% | -4.42▼ 262.3% | -3.30▲ 25.3% | -2.85▲ 13.6% | -2.12▲ 25.6% | -1.83▲ 0% |
EPS Growth % | - | -199.5% | -577.78% | -262.3% | 25.34% | 13.64% | 25.61% | 32.91% |
EPS (Basic) | -0.06 | -0.53 | -1.22 | -4.42 | -3.30 | -2.85 | -2.12 | - |
Diluted Shares Outstanding | 22.39M | 22.39M | 22.39M | 15.64M | 23.8M | 31.58M | 42.22M | 42.22M |
Basic Shares Outstanding | 22.39M | 7.72M | 22.39M | 15.64M | 23.8M | 31.58M | 42.22M | 69.09M |
Dividend Payout Ratio | - | - | - | - | - | - | - | - |
PEPG Balance Sheet
PepGen Inc. (PEPG) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|
Total Current Assets | 3.77M | 10.32M | 139.99M | 186.08M | 112.68M | 123.76M | 150.96M | 134.27M |
Cash & Short-Term Investments | 3.49M | 9.78M | 132.9M | 181.75M | 110.41M | 120.19M | 148.46M | 132.3M |
Cash Only | 3.49M | 9.78M | 132.9M | 181.75M | 80.77M | 49.42M | 60.51M | 42.15M |
Short-Term Investments | 0 | 0 | 0 | 0 | 29.63M | 70.77M | 87.94M | 90.15M |
Accounts Receivable | 230K | 407K | 4.74M | 58K | 0 | 0 | 0 | 0 |
Days Sales Outstanding | - | - | - | - | - | - | - | - |
Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Days Inventory Outstanding | - | - | - | - | - | - | - | - |
Other Current Assets | 0 | 0 | 0 | 4.27M | 2.27M | 3.57M | 2.51M | 1.97M |
Total Non-Current Assets | 419K | 323K | 3.65M | 31.36M | 30.37M | 27.12M | 22.94M | 22.02M |
Property, Plant & Equipment | 419K | 323K | 636K | 29.88M | 28.38M | 25.15M | 21.02M | 20.09M |
Fixed Asset Turnover | - | - | - | - | - | - | - | 0.00x |
Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long-Term Investments | 0 | 0 | 1.47M | 0 | 0 | 0 | 0 | 1.55M |
Other Non-Current Assets | 0 | 0 | 1.55M | 1.47M | 1.99M | 1.97M | 1.92M | 1.94M |
Total Assets | 4.19M▲ 0% | 10.64M▲ 153.8% | 143.64M▲ 1249.8% | 217.44M▲ 51.4% | 143.05M▼ 34.2% | 150.88M▲ 5.5% | 173.91M▲ 15.3% | 156.29M▲ 0% |
Asset Turnover | - | - | - | - | - | - | - | 0.00x |
Asset Growth % | - | 153.8% | 1249.76% | 51.38% | -34.21% | 5.47% | 15.26% | 2.43% |
Total Current Liabilities | 326K | 838K | 10.32M | 18.83M | 17.53M | 16.7M | 12.65M | 8.96M |
Accounts Payable | 141K | 721K | 3.24M | 1.36M | 1M | 1.75M | 822K | 622K |
Days Payables Outstanding | 485.52 | - | - | - | 309.82 | 424.9 | 214.77 | 163.04 |
Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 3.19M | 3.21M |
Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 28K | 1.21M | 2.44M | 2.37M | 3.62M | 8.64M | 5.13M |
Current Ratio | 11.58x | 12.31x | 13.56x | 9.88x | 6.43x | 7.41x | 11.94x | 14.98x |
Quick Ratio | 11.58x | 12.31x | 13.56x | 9.88x | 6.43x | 7.41x | 11.94x | 14.98x |
Cash Conversion Cycle | - | - | - | - | - | - | - | - |
Total Non-Current Liabilities | 0 | 30K | 226K | 18.98M | 17.1M | 15.57M | 13.82M | 13.35M |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 13.82M | 13.35M |
Capital Lease Obligations | 0 | 0 | 0 | 18.98M | 17.1M | 15.57M | 0 | 42.82M |
Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | 30K | 226K | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 326K | 868K | 10.55M | 37.81M | 34.63M | 32.26M | 26.46M | 22.32M |
Total Debt | 0 | 0 | 0 | 24.53M | 20.1M | 18.66M | 17M | 16.56M |
Net Debt | -3.49M | -9.78M | -132.9M | -157.22M | -60.67M | -30.76M | -43.51M | -25.59M |
Debt / Equity | - | - | - | 0.14x | 0.19x | 0.16x | 0.12x | 0.12x |
Debt / EBITDA | - | - | - | - | - | - | - | -0.20x |
Net Debt / EBITDA | - | - | - | - | - | - | - | 0.32x |
Interest Coverage | - | - | - | - | - | - | - | - |
Total Equity | 3.87M▲ 0% | 9.77M▲ 152.8% | 133.09M▲ 1261.7% | 179.63M▲ 35.0% | 108.42M▼ 39.6% | 118.62M▲ 9.4% | 147.44M▲ 24.3% | 133.98M▲ 0% |
Equity Growth % | - | 152.75% | 1261.71% | 34.97% | -39.64% | 9.41% | 24.3% | 34.82% |
Book Value per Share | 0.17 | 0.44 | 5.94 | 11.49 | 4.56 | 3.76 | 3.49 | 3.17 |
Total Shareholders' Equity | 3.87M | 9.77M | 133.09M | 179.63M | 108.42M | 118.62M | 147.44M | 133.98M |
Common Stock | 0 | 0 | 0 | 2K | 2K | 3K | 7K | 7K |
Retained Earnings | -2.39M | -6.47M | -33.75M | -102.86M | -181.48M | -271.46M | -361.12M | -378.88M |
Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accumulated OCI | -8K | -8K | 17K | -81K | 34K | 23K | 11K | -59K |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
PEPG Cash Flow Statement
PepGen Inc. (PEPG) cash flow — operating, investing & free cash flow history
| Metric | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|
Cash from Operations | -885K | -1.65M | -22.6M | -59.27M | -69M | -82.37M | -81.64M | -77.13M |
Operating CF Margin % | - | - | - | - | - | - | - | - |
Operating CF Growth % | - | -86.67% | -1267.98% | -162.25% | -16.42% | -19.38% | 0.89% | 13.75% |
Net Income | -1.35M | -1.89M | -27.28M | -69.1M | -78.63M | -89.98M | -89.66M | -77.22M |
Depreciation & Amortization | 106K | 110K | 178K | 493K | 850K | 5.25M | 5.14M | 3.2M |
Stock-Based Compensation | 0 | 119K | 1.53M | 4.76M | 7.05M | 11.46M | 10.61M | 4.8M |
Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Cash Items | 59K | 0 | 196K | 76K | -220K | -3.85M | -1.51M | 5.46M |
Working Capital Changes | 296K | 8K | 2.77M | 4.51M | 1.95M | -5.25M | -6.22M | -13.38M |
Change in Receivables | -112K | -170K | -4.34M | 4.18M | 26K | 0 | 0 | 0 |
Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Change in Payables | 59K | 331K | 2.51M | -1.41M | -369K | 722K | -935K | -2.06M |
Cash from Investing | -29K | -8K | -500K | -3.75M | -32M | -37.67M | -15.23M | -33.84M |
Capital Expenditures | -29K | -8K | -500K | -3.75M | -2.6M | -497K | -264K | -139K |
CapEx % of Revenue | - | - | - | - | - | - | - | - |
Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments | - | - | - | - | - | - | - | - |
Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash from Financing | 2.79M | 7.95M | 147.66M | 112.19M | -189K | 88.75M | 107.98M | 109.5M |
Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Equity Issued (Net) | 2.79M | 7.96M | 149.04M | 114.27M | 0 | 86.78M | 107.98M | 109.49M |
Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Financing | 0 | -3K | -1.39M | -2.07M | -189K | 1.97M | 0 | 7K |
Net Change in Cash | 1.88M▲ 0% | 6.29M▲ 235.1% | 124.59M▲ 1881.7% | 48.86M▼ 60.8% | -100.9M▼ 306.5% | -31.35M▲ 68.9% | 11.09M▲ 135.4% | -1.48M▲ 0% |
Free Cash Flow | -914K▲ 0% | -1.66M▼ 81.6% | -23.1M▼ 1291.5% | -63.02M▼ 172.8% | -71.6M▼ 13.6% | -82.87M▼ 15.7% | -81.9M▲ 1.2% | -77.27M▲ 0% |
FCF Margin % | - | - | - | - | - | - | - | - |
FCF Growth % | - | -81.62% | -1291.51% | -172.83% | -13.61% | -15.75% | 1.17% | 7.28% |
FCF per Share | -0.04 | -0.07 | -1.03 | -4.03 | -3.01 | -2.62 | -1.94 | -1.83 |
FCF Conversion (FCF/Net Income) | 0.66x | 0.87x | 0.83x | 0.86x | 0.88x | 0.92x | 0.91x | 1.00x |
Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Taxes Paid | 0 | 0 | 0 | 0 | 2.7M | 71K | 0 | 0 |
PEPG Key Ratios
PepGen Inc. (PEPG) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | -27.7% | -38.19% | -44.19% | -54.59% | -79.26% | -67.39% | -59.89% |
Return on Invested Capital (ROIC) | -756.85% | -20853.08% | -453.08% | -181.22% | -108.11% | -73.21% | -80.14% |
Debt / Equity | - | - | 0.14x | 0.19x | 0.16x | 0.12x | 0.12x |
FCF Conversion | 0.87x | 0.83x | 0.86x | 0.88x | 0.92x | 0.91x | 1.00x |
Related:PEPG Dividend History·PEPG Revenue History·PEPG Price History·PEPG P/E History·PEPG Financial Ratios·PEPG Institutional Holders
PEPG SEC Filings & Documents
PepGen Inc. (PEPG) SEC filings — annual & quarterly reports (10-K, 10-Q)
PEPG Frequently Asked Questions
PepGen Inc. (PEPG) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
PepGen Inc. (PEPG) grew revenue by 0.0% over the past year. Growth has been modest.
PepGen Inc. (PEPG) reported a net loss of $77.2M for fiscal year 2025.
Dividend & Returns
PepGen Inc. (PEPG) has a return on equity (ROE) of -67.4%. Negative ROE indicates the company is unprofitable.
PepGen Inc. (PEPG) had negative free cash flow of $77.3M in fiscal year 2025, likely due to heavy capital investments.